These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2150031)

  • 1. Cardiac volume load as a determinant of the response of cardiac mass to antihypertensive therapy.
    Leenen FH; Tsoporis J
    Eur Heart J; 1990 Nov; 11 Suppl G():100-6. PubMed ID: 2150031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of cardiac hypertrophy after therapy in animal hypertension.
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S56-61. PubMed ID: 2409372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats.
    Tsoporis J; Leenen FH
    Hypertension; 1988 Apr; 11(4):376-86. PubMed ID: 2895737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basis and clinical significance of regression of hypertensive hypertrophy.
    Motz W; Zähringer J; Strauer BE
    Basic Res Cardiol; 1986; 81 Suppl 1():171-8. PubMed ID: 2947563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods for studying vasodilator agents in arterial hypertension].
    Laurent S; Asmar R; Pannier B; London G; Safar M
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():69-73. PubMed ID: 2140502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans.
    Leenen FH; Smith DL; Farkas RM; Reeves RA; Marquez-Julio A
    Am J Med; 1987 May; 82(5):969-78. PubMed ID: 2953239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular adjustment to antiadrenergic agents.
    Pegram BL; Frohlich ED
    Am J Med; 1983 Sep; 75(3A):94-9. PubMed ID: 6137951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of antihypertensive therapy upon myosin isozyme distribution in spontaneously hypertensive rats.
    Sen S; Young D
    J Hypertens; 1992 Aug; 10(8):749-56. PubMed ID: 1325506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of structural cardiovascular changes by antihypertensive therapy.
    Motz W; Strauer BE
    Hypertension; 1984; 6(6 Pt 2):III133-9. PubMed ID: 6240446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
    Thandapilly SJ; Louis XL; Behbahani J; Movahed A; Yu L; Fandrich R; Zhang S; Kardami E; Anderson HD; Netticadan T
    Hypertens Res; 2013 Oct; 36(10):866-72. PubMed ID: 23784505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
    Rodrigues Junior LF; de Azevedo Carvalho AC; Pimentel EB; Mill JG; Nascimento JH
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):225-234. PubMed ID: 27915452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress.
    Yu XJ; Zhang DM; Jia LL; Qi J; Song XA; Tan H; Cui W; Chen W; Zhu GQ; Qin DN; Kang YM
    Toxicol Appl Pharmacol; 2015 May; 284(3):315-22. PubMed ID: 25759242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy and arterial blood pressure in experimental models of hypertension.
    Dominiczak AF; Devlin AM; Brosnan MJ; Anderson NH; Graham D; Clark JS; McPhaden A; Hamilton CA; Reid JL
    Adv Exp Med Biol; 1997; 432():23-33. PubMed ID: 9433508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.